[PDF] Top 20 La musicoterapia dentro del contexto de la parálisis cerebral
Has 10000 "La musicoterapia dentro del contexto de la parálisis cerebral" found on our website. Below are the top 20 most common "La musicoterapia dentro del contexto de la parálisis cerebral".
Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%)
... States, glaucoma is the second leading cause of blindness in the gen- eral population, and the leading cause of blindness in black ...of glaucoma (Hayreh 1969; Ernest 1975; Sossi and Anderson ...open-angle ... See full document
32
Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
... routine glaucoma consul- tations or through solicitation if they were identified as potentially eligible based on investigator ...and timolol 0.5% administered concomitantly or in a fixed ... See full document
12
Comparative Evaluation of the Efficacy of the Bimatoprost 0 03%, Brimonidine 0 2%, Brinzolamide 1%, Dorzolamide 2%, and Travoprost 0 004%/Timolol 0 5% Fixed Combinations in Patients Affected by Open Angle Glaucoma
... open-angle glaucoma and IOP > 25 ...our Glaucoma Service were retrospectively analyzed as long as 12 ...the 5 groups of the fixed combinations ...the fixed combinations were ... See full document
33
Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice
... Results: A total of 1,553 patients were included in the study, and the per-protocol population comprised 1,391 patients. There were some minor deviations from protocol: some patients with no prior therapy and some who ... See full document
16
The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
... the fixed combination, ...the timolol 0.5% (10.3%) and fixed-combination ...the fixed-combination group (3.2%) than in the bimatoprost arm ...that timolol ... See full document
8
Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose–response phenomenon
... open-angle glaucoma or ocular hypertension (12/17). All studies investigated timolol in preserved ...formulations. Timolol concentrations tested ranged from ... See full document
10
Fixed-combination treatments for intraocular hypertension in Chinese patients – focus on bimatoprost-timolol
... 0.03% bimatoprost and 0.5% timolol), followed by one drop of vehicle, for masking, once daily at 7:00 pm, and the unfixed-combination group received one drop of ...0.03% bimatoprost followed ... See full document
35
Managing adverse effects of glaucoma medications
... in fixed- combination eye drops include those administered when each agent is administered ...because fixed- combination medications were usually administered at lower frequencies, eye surface ... See full document
22
Fixed combination of bimatoprost and timolol in patients with primary open-angle glaucoma or ocular hypertension with inadequate IOP adjustment
... was timolol-based in the majority of patients ...in combination with other ...using bimatoprost and timolol as an adjunctive ...of glaucoma-related damage ...of glaucoma-related ... See full document
7
Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
... Background: Fixed-combination ocular hypotensives have multiple advantages, but triple-therapy dorzolamide/ brimonidine/timolol (dorz/brim/tim) is only available in Latin and South America, and ... See full document
9
Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China
... Patients reported greater satisfaction with BTFC than with their previous treatment. Mean ( ± standard deviation, SD) satisfaction scores in the total patient population were 7.8 ± 1.6 for BTFC versus 6.0 ± 1.5 for ... See full document
8
A combined analysis of five observational studies evaluating the efficacy and tolerability of bimatoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension
... Methods: Patient data were combined (n = 5556) from five multicenter, observational, non- controlled, open-label studies throughout Europe. Patients were identified from 830 sites in Austria, France, Germany, The ... See full document
10
A Comparative Evaluation of Efficacy and Tolerability of Fixed Drug Combination of Brimonidine and Timolol with Timolol Monotherapy in Patients with Primary Open-Angle Glaucoma: An Open Labeled Prospective Study
... 1. Latanoprost (0.005%). It is a synthetic drug, an ester analogue of prostaglandin F2-α. It s acts by increasing uveoscleral outflow and by causing reduction in episcleral venous pressure. It is as effective as ... See full document
178
The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study
... Patients were enrolled between January 2015 and March 2016, after informed written consent was provided. Each patient initially continued to receive latanoprost (pre- served with 0.02% BAC) monotherapy, applied once ... See full document
22
Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy
... Eligible participants were aged 18 years and were diag- nosed with primary open-angle glaucoma, pigmentary glaucoma, or ocular hypertension. Additional inclusion criteria were a stable IOP-lowering ... See full document
15
Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study
... or fixed combination) within 1 year before screening; women who were pregnant or lactating or could become pregnant during the study; and participation in any other investigational study within 30 days ... See full document
6
Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension
... Patients received either TIM ophthalmic solution or BRINZ/ TIM-FC ophthalmic suspension. Matched placebos for TIM and BRINZ/TIM-FC (both consisting of aqueous ophthalmic solutions containing no active ingredients) were ... See full document
27
Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension
... Other factors besides IOP may be influential in the pathogenesis of glaucoma and therefore are important to consider when evaluating treatment options. Ocular perfusion is increasingly recognized as potentially ... See full document
12
BCI-1. ) = 0 BCI-2. = 0 BCI-3. = 0 BCI-4. = 0 and = 0 implies that BCI-5. 0= 0, for all
... Assume that (X,∗ ,0) is a BCL-algebra, then the BCL- ordering ≤ is a partial ordering on 𝑋𝑋 . By definition of ≤ , (2) is valid. Also, BCL-3 and (2) imply (1). Conversely, assume that ≤ a partial ordering on 𝑋𝑋 , ... See full document
28
Comparison between bimatoprost and latanoprost-timolol fixed combination for efficacy and safety after switching patients from latanoprost
... The results of the current study indicated no differences in IOP reduction in the bimatoprost and LTFC groups, suggest- ing that both treatments can be considered for use in patients with uncontrolled IOP after ... See full document
8
Related subjects